US HB298 | 2015-2016 | 114th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on January 13 2015 - 25% progression, died in committee
Action: 2015-01-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 13 2015 - 25% progression, died in committee
Action: 2015-01-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Medical Testing Availability Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a product labeled for research use only from being deemed adulterated or misbranded on the basis that its manufacturer or distributor: (1) sells the product to an end user who uses the product for a purpose other than research, or (2) engages in business communications with an end user regarding the product.
Title
Medical Testing Availability Act of 2015
Sponsors
| Rep. Michael Burgess [R-TX] | Rep. Jackie Speier [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2015-01-16 | House | Referred to the Subcommittee on Health. |
| 2015-01-13 | House | Referred to the House Committee on Energy and Commerce. |
| 2015-01-13 | House | Introduced in House |
Subjects
Consumer affairs
Drug safety, medical device, and laboratory regulation
Health
Health technology, devices, supplies
Medical research
Product safety and quality
Drug safety, medical device, and laboratory regulation
Health
Health technology, devices, supplies
Medical research
Product safety and quality
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-bill/298/all-info |
| Text | https://www.congress.gov/114/bills/hr298/BILLS-114hr298ih.pdf |
